| Primary |
| Drug Use For Unknown Indication |
37.3% |
| Angina Pectoris |
14.5% |
| Product Used For Unknown Indication |
9.6% |
| Coronary Artery Disease |
7.2% |
| Ischaemic Cardiomyopathy |
6.0% |
| Angina Unstable |
2.4% |
| Cardiac Failure |
2.4% |
| Hypertensive Heart Disease |
2.4% |
| Ischaemia |
2.4% |
| Off Label Use |
2.4% |
| Ventricular Dysfunction |
2.4% |
| Acute Coronary Syndrome |
1.2% |
| Arteriosclerosis |
1.2% |
| Cardiac Disorder |
1.2% |
| Chest Pain |
1.2% |
| Dementia |
1.2% |
| Enhanced External Counterpulsation |
1.2% |
| Hypertension |
1.2% |
| Muscle Spasms |
1.2% |
| Myocardial Ischaemia |
1.2% |
|
| Death |
19.0% |
| Pharmaceutical Product Complaint |
10.3% |
| Rash |
10.3% |
| Headache |
5.2% |
| Product Adhesion Issue |
5.2% |
| Tachycardia |
5.2% |
| Dermatitis Contact |
3.4% |
| Drug Ineffective |
3.4% |
| Erythema |
3.4% |
| Hallucination |
3.4% |
| Myocardial Infarction |
3.4% |
| Product Quality Issue |
3.4% |
| Pruritus Generalised |
3.4% |
| Sudden Death |
3.4% |
| Suicide Attempt |
3.4% |
| Syncope |
3.4% |
| Therapeutic Product Ineffective |
3.4% |
| Thrombocytopenia |
3.4% |
| Application Site Rash |
1.7% |
| Breast Cancer Female |
1.7% |
|
| Secondary |
| Pneumonitis |
16.9% |
| Pneumonia |
12.7% |
| Type 2 Diabetes Mellitus |
8.5% |
| Angina Unstable |
7.0% |
| Anticoagulant Therapy |
7.0% |
| Cardiomegaly |
7.0% |
| Essential Hypertension |
7.0% |
| Polyuria |
7.0% |
| Gastrooesophageal Reflux Disease |
5.6% |
| Cardiac Disorder |
4.2% |
| Drug Use For Unknown Indication |
4.2% |
| Angina Pectoris |
2.8% |
| Diabetes Mellitus |
2.8% |
| Cardiac Failure |
1.4% |
| Hypertension |
1.4% |
| Hypertensive Cardiomyopathy |
1.4% |
| Nasopharyngitis |
1.4% |
| Prophylaxis |
1.4% |
|
| Death |
24.0% |
| Tendonitis |
24.0% |
| Thrombocytopenia |
12.0% |
| Angina Pectoris |
8.0% |
| Anosmia |
4.0% |
| Chest Pain |
4.0% |
| Drug Ineffective |
4.0% |
| Medication Error |
4.0% |
| Myocardial Infarction |
4.0% |
| Product Quality Issue |
4.0% |
| Speech Disorder |
4.0% |
| White Blood Cell Count Increased |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.1% |
| Drug Use For Unknown Indication |
17.2% |
| Hypertension |
10.0% |
| Cardiac Disorder |
5.1% |
| Angina Pectoris |
4.8% |
| Pain |
3.7% |
| Arthritis |
2.6% |
| Chest Pain |
2.6% |
| Atrial Fibrillation |
2.4% |
| Hyperlipidaemia |
2.3% |
| Multiple Myeloma |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Diabetes Mellitus |
2.1% |
| Prophylaxis |
1.9% |
| Depression |
1.8% |
| Coronary Artery Disease |
1.7% |
| Hypercholesterolaemia |
1.5% |
| Ill-defined Disorder |
1.5% |
| Prostate Cancer |
1.5% |
| Osteoporosis |
1.5% |
|
| Myocardial Infarction |
12.1% |
| Vomiting |
11.7% |
| Pain |
8.3% |
| Pneumonia |
7.8% |
| Transient Ischaemic Attack |
6.8% |
| Weight Decreased |
5.8% |
| Pneumothorax |
4.9% |
| Death |
4.4% |
| Syncope |
4.4% |
| Diabetes Mellitus |
3.9% |
| Hypoglycaemia |
3.9% |
| Type 2 Diabetes Mellitus |
3.4% |
| Cardiac Disorder |
2.9% |
| Chest Pain |
2.9% |
| Pelvic Fracture |
2.9% |
| Respiratory Failure |
2.9% |
| Thrombosis |
2.9% |
| Tremor |
2.9% |
| Wheezing |
2.9% |
| Cardiac Failure Congestive |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
44.4% |
| Acute Coronary Syndrome |
33.3% |
| Myocardial Ischaemia |
22.2% |
|
|
